Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Immune Checkpoint Inhibition as a Strategy in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

The treatment of locally advanced rectal cancer (LARC) has seen major advances over the past 3 decades, with multimodality treatment now standard of care. Combining surgical resection with radiotherapy and/or chemotherapy can reduce local recurrence from around 20% to approximately 5%. Despite impro...

Full description

Bibliographic Details
Main Authors: Catherine R. Hanna, Séan M. O’Cathail, Janet Graham, Richard Adams, Campbell S.D. Roxburgh
Format: Article
Language:English
Published: Innovative Healthcare Institute 2021-05-01
Series:Journal of Immunotherapy and Precision Oncology
Subjects:
neoplasm
rectum
radiotherapy
chemotherapy
immunotherapy
immunology
clinical trials
immune checkpoint inhibitor
colorectal cancer
Online Access:https://jipo.org/doi/pdf/10.36401/JIPO-20-31

Internet

https://jipo.org/doi/pdf/10.36401/JIPO-20-31

Similar Items